---
category: listing
circular_id: 36e59a21a6dc0697
date: '2025-09-09'
description: ISIN code change for Fischer Medical Ventures Limited equity shares effective
  September 12, 2025 due to sub-division from Rs. 10/- to Re. 1/-
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML70107.pdf
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Corporate action affecting share identification and trading systems
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML70107.pdf
processing:
  attempts: 1
  content_hash: 168fb45f79edfe52
  processed_at: '2025-09-09T15:43:52.092970'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-09-09T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML70107.pdf
severity: medium
source: nse
stocks:
- FISCHER
tags:
- isin-change
- sub-division
- share-split
- corporate-action
title: Change in ISIN - Fischer Medical Ventures Limited due to Sub-Division
---

## Summary

NSE has announced a change in ISIN code for Fischer Medical Ventures Limited (FISCHER) due to sub-division of equity shares from face value Rs. 10/- to Re. 1/-. The new ISIN INE771F01041 will be effective from September 12, 2025.

## Key Points

- Company: Fischer Medical Ventures Limited
- Symbol: FISCHER
- New ISIN: INE771F01041
- Corporate Action: Sub-division from Rs. 10/- to Re. 1/-
- Effective Date: September 12, 2025

## Regulatory Changes

ISIN code change from existing code to INE771F01041 to reflect the new face value structure post sub-division.

## Compliance Requirements

- All members must note the new ISIN code
- Trading systems must be updated to reflect the new ISIN
- All trades from ex-date onwards will use the new ISIN

## Important Dates

- **Ex-Date**: September 12, 2025 - New ISIN becomes effective for all trades
- **Circular Date**: September 9, 2025

## Impact Assessment

Medium impact on trading operations as members need to update their systems with the new ISIN. The sub-division will increase the number of shares outstanding while reducing the face value, making shares more affordable for retail investors.